Gene Therapy, Oncolytic Viruses, Viral Vaccines CDMO Services

Our gene therapy viral vector process development and manufacturing capabilities are designed to confidently and rapidly progress your products from gene to market through development of robust and reproducible cGMP practices. Our technical teams have a deep understanding of viral vectors (AAV, Adenovirus, HSV, Lentivirus), oncolytic viruses, and viral vaccines.